NYQ · Financial Statements

Nu Skin Enterprises, Inc. (NUS) Financial Statements

$4.79 NYQ: NUS Market Cap $233.16M

Nu Skin Enterprises, Inc. most recently reported annual revenue of $1.5B, net profit of $160.0M. Revenue declined at an average annual rate of 10.5% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Nu Skin Enterprises, Inc.: Revenue fell from $2.2B in 2016 to $1.5B in 2025, a change of -32.7% over 9 years; net profit was positive in 9 of 10 reported years; operating margin moved from 10.5% to 6.1%, a shift of -4.4 percentage points; the most recent year shows net profit of $160.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$2.2B$2.3B$2.7B$2.4B$2.6B$2.7B$2.2B$2.0B$1.7B$1.5B
Operating Expenses$2.0B$2.0B$2.4B$2.2B$2.3B$2.5B$2.1B$1.9B$1.9B$1.4B
Operating Profit$231.0M$274.0M$241.0M$267.0M$258.0M$234.0M$111.0M$48.0M$-152.0M$91.0M
Operating Margin10.5%12.0%9.0%11.1%10.0%8.7%5.0%2.5%-8.8%6.1%
Other Income$-18.0M$-9.0M$-21.0M$-12.0M$-1.0M$-2.0M$-22.0M$-22.0M$-23.0M$105.0M
Interest$0$0$0$19.0M$13.0M$11.0M$22.0M$26.0M$26.0M$14.0M
Depreciation$72.0M$72.0M$83.0M$77.0M$74.0M$125.0M$73.0M$69.0M$70.0M$52.0M
Profit Before Tax$213.0M$266.0M$220.0M$255.0M$256.0M$232.0M$89.0M$27.0M$-175.0M$196.0M
Tax$32.8M$51.3M$44.5M$32.0M$25.3M$36.6M$-17.8M$67.7M$16.3M$18.4M
Net Profit$143.0M$129.0M$122.0M$174.0M$191.0M$147.0M$105.0M$9.0M$-147.0M$160.0M
EPS$2.55$2.36$2.16$3.10$3.63$2.86$2.07$0.17$-2.95$3.18
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$499.0M$489.0M$417.0M$439.0M$430.0M$446.0M$364.0M$386.0M$364.0M$370.0M$321.0M$320.0M
Operating Expenses$525.0M$473.0M$408.0M$565.0M$412.0M$499.0M$374.0M$355.0M$343.0M$347.0M$315.0M$379.0M
Operating Profit$-26.0M$16.0M$9.0M$-126.0M$18.0M$-53.0M$-10.0M$31.0M$22.0M$23.0M$6.0M$-59.0M
Operating Margin-5.3%3.3%2.1%-28.6%4.2%-11.9%-2.7%8.0%5.9%6.3%1.8%-18.5%
Interest$8.0M$0$7.0M$7.0M$7.0M$6.0M$3.0M$3.0M$4.0M$4.0M$4.0M$3.0M
Profit Before Tax$-34.0M$9.0M$1.0M$-132.0M$13.0M$-58.0M$135.0M$27.0M$16.0M$18.0M$3.0M$-63.0M
Tax$-7.3M$21.9M$148.4M$10.2M$37.6M$37.5M$20.1M$22.9M$-6.8M$20.3M$29.4M$-295.4M
Net Profit$-37.0M$7.0M$-1.0M$-118.0M$8.0M$-36.0M$108.0M$21.0M$17.0M$14.0M$2.0M$-250.0M
EPS$-0.74$0.15$-0.01$-2.38$0.17$-0.73$2.14$0.43$0.34$0.29$0.04$-5.14

Over the 10 years reported for Nu Skin Enterprises, Inc., borrowings decreased from $417.0M in 2016 to $364.0M in 2025, cash stood at $239.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 2.08 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$1.5B$1.6B$1.7B$1.8B$2.0B$1.9B$1.8B$1.8B$1.5B$1.4B
Current Assets$714.0M$778.0M$799.0M$740.0M$903.0M$873.0M$760.0M$702.0M$539.0M$548.0M
Cash$357.0M$426.0M$387.0M$336.0M$403.0M$340.0M$265.0M$256.0M$187.0M$239.0M
Inventory$250.0M$253.0M$296.0M$276.0M$314.0M$400.0M$346.0M$280.0M$190.0M$179.0M
Receivables$31.0M$33.0M$53.0M$50.0M$63.0M$41.0M$47.0M$73.0M$51.0M$40.0M
Fixed Assets$445.0M$465.0M$465.0M$645.0M$653.0M$598.0M$572.0M$523.0M$467.0M$451.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$-25.0M$-22.0M$-26.0M$8.0M$33.0M$51.0M$53.0M$52.0M$51.0M$20.0M
Other Assets$115.0M$115.0M$197.0M$197.0M$203.0M$206.0M$206.0M$231.0M$84.0M$84.0M
Total Liabilities$810.0M$885.0M$913.0M$894.0M$1.1B$994.0M$924.0M$984.0M$817.0M$600.0M
Current Liabilities$399.0M$447.0M$440.0M$357.0M$543.0M$530.0M$359.0M$329.0M$297.0M$264.0M
Borrowings$417.0M$389.0M$430.0M$507.0M$500.0M$504.0M$521.0M$607.0M$478.0M$364.0M
Other Liabilities$393.0M$497.0M$482.0M$387.0M$562.0M$490.0M$403.0M$377.0M$339.0M$236.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$664.0M$705.0M$782.0M$875.0M$894.0M$913.0M$897.0M$822.0M$651.0M$805.0M

For Nu Skin Enterprises, Inc., operating cash flow was positive in 10 of 10 reported years; free cash flow in the latest year was $46.0M; free cash flow was positive in 10 of 10 years; financing activities used $19.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$275.0M$303.0M$203.0M$178.0M$379.0M$142.0M$108.0M$119.0M$112.0M$80.0M
Investing Cash Flow$-107.0M$-152.0M$-179.0M$-137.0M$-143.0M$-157.0M$-126.0M$-193.0M$-80.0M$136.0M
Financing Cash Flow$-234.0M$-47.0M$-66.0M$-3.0M$-139.0M$-67.0M$-48.0M$-16.0M$-8.0M$-19.0M
Net Cash Flow$68.0M$69.0M$-39.0M$-51.0M$67.0M$-63.0M$-75.0M$-9.0M$-69.0M$52.0M
Free Cash Flow$225.0M$242.0M$132.0M$112.0M$315.0M$73.0M$49.0M$60.0M$70.0M$46.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA7.58
FCF Yield4.82%
Quick Ratio1.24
Interest Coverage-0.55
Return 1Y-46.75%
Return 3Y-80.45%
Return 5Y-88.97%

Nu Skin Enterprises, Inc. (NUS) financials — frequently asked questions

What is Nu Skin Enterprises, Inc.'s annual revenue?

Nu Skin Enterprises, Inc. (NUS) reported annual revenue of $1.5B in its most recent fiscal year.

What is Nu Skin Enterprises, Inc.'s net profit?

Nu Skin Enterprises, Inc. (NUS) reported net profit of $160.0M in its most recent fiscal year.

What is NUS EV/EBITDA?

Nu Skin Enterprises, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 7.58.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Consumer Defensive StocksLow P/E Consumer Defensive StocksHigh Net Margin Consumer Defensive StocksDividend Consumer Defensive StocksLow Debt Consumer Defensive StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
NUS Overview NUS Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.